Loading…

Evaluation of the Cholesterol-Lowering Mechanism of IEnterococcus faecium/I Strain 132 and ILactobacillus paracasei/I Strain 201 in Hypercholesterolemia Rats

Hypercholesterolemia can cause many diseases, but it can effectively regulated by Lactobacillus. This study aimed to evaluate the cholesterol-lowering mechanism of Enterococcus faecium strain 132 and Lactobacillusparacasei strain 201. These results showed that both the strains decreased serum total...

Full description

Saved in:
Bibliographic Details
Published in:Nutrients 2021-06, Vol.13 (6)
Main Authors: Yang, Lingshuang, Xie, Xinqiang, Li, Ying, Wu, Lei, Fan, Congcong, Liang, Tingting, Xi, Yu, Yang, Shuanghong, Li, Haixin, Zhang, Jumei, Ding, Yu, Xue, Liang, Chen, Moutong, Wang, Juan, Wu, Qingping
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 6
container_start_page
container_title Nutrients
container_volume 13
creator Yang, Lingshuang
Xie, Xinqiang
Li, Ying
Wu, Lei
Fan, Congcong
Liang, Tingting
Xi, Yu
Yang, Shuanghong
Li, Haixin
Zhang, Jumei
Ding, Yu
Xue, Liang
Chen, Moutong
Wang, Juan
Wu, Qingping
description Hypercholesterolemia can cause many diseases, but it can effectively regulated by Lactobacillus. This study aimed to evaluate the cholesterol-lowering mechanism of Enterococcus faecium strain 132 and Lactobacillusparacasei strain 201. These results showed that both the strains decreased serum total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), triglycerides (TG), liver TC and TG and increased fecal TC, TG and total bile acid (TBA) levels. Additionally, both strains also reduced glutamic-pyruvic transaminase (ALT), glutamic oxaloacetic transaminase (AST) and levels of tissue inflammation levels to improve the lipid profile, and they reduced fat accumulation partially by alleviating inflammatory responses. Furthermore, both strains regulated the expression of the CYP8B1, CYP7A1, SREBP-1, SCD1 and LDL-R gene to promote cholesterol metabolism and reduce TG accumulation. Interventions with both strains also altered the gut microbiota, and decreasing the abundance of Veillonellaceae, Erysipelotrichaceae and Prevotella. Furthermore, fecal acetic acid and propionic acid were increased by this intervention. Overall, the results suggested that E. faecium strain 132 and L. paracasei strain 201 can alleviate hypercholesterolemia in rats and might be applied as a new type of hypercholesterolemia agent in functional foods.
doi_str_mv 10.3390/nu13061982
format article
fullrecord <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A765644471</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A765644471</galeid><sourcerecordid>A765644471</sourcerecordid><originalsourceid>FETCH-LOGICAL-g671-3d4cf8bd7dd5cd8cdea12592c8b6755594b79f27d2504581567bcb1bb8e5ffcd3</originalsourceid><addsrcrecordid>eNptjlFLwzAQx4MoOOZe_AQBn7s1aZO0j2NMV6gIuveRXJIt0iajaRU_jN_VDoXtwbuH_3H3u7s_QvcknWdZmS78QLKUk7KgV2hCU0ETzvPs-qK-RbMY39NTiFTwbIK-1x-yGWTvgsfB4v5g8OoQGhN704UmqcOn6Zzf42cDB-ldbE9UtfanMQSAIWIrDbihXVT4re-k85hkFEuvcVVL6IOS4Jpm5I6ykyCjcWeSpgSPsvk6mg7Ob03rJH6VfbxDN1Y20cz-dIq2j-vtapPUL0_Valkney5IkukcbKG00JqBLkAbSSgrKRSKC8ZYmStRWio0ZWnOCsK4UKCIUoVh1oLOpujh9-xeNmbnvA2jPWhdhN1ScMbzPBdkpOb_UGPq0S8Eb6wb-xcLPwmAfAg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Evaluation of the Cholesterol-Lowering Mechanism of IEnterococcus faecium/I Strain 132 and ILactobacillus paracasei/I Strain 201 in Hypercholesterolemia Rats</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Yang, Lingshuang ; Xie, Xinqiang ; Li, Ying ; Wu, Lei ; Fan, Congcong ; Liang, Tingting ; Xi, Yu ; Yang, Shuanghong ; Li, Haixin ; Zhang, Jumei ; Ding, Yu ; Xue, Liang ; Chen, Moutong ; Wang, Juan ; Wu, Qingping</creator><creatorcontrib>Yang, Lingshuang ; Xie, Xinqiang ; Li, Ying ; Wu, Lei ; Fan, Congcong ; Liang, Tingting ; Xi, Yu ; Yang, Shuanghong ; Li, Haixin ; Zhang, Jumei ; Ding, Yu ; Xue, Liang ; Chen, Moutong ; Wang, Juan ; Wu, Qingping</creatorcontrib><description>Hypercholesterolemia can cause many diseases, but it can effectively regulated by Lactobacillus. This study aimed to evaluate the cholesterol-lowering mechanism of Enterococcus faecium strain 132 and Lactobacillusparacasei strain 201. These results showed that both the strains decreased serum total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), triglycerides (TG), liver TC and TG and increased fecal TC, TG and total bile acid (TBA) levels. Additionally, both strains also reduced glutamic-pyruvic transaminase (ALT), glutamic oxaloacetic transaminase (AST) and levels of tissue inflammation levels to improve the lipid profile, and they reduced fat accumulation partially by alleviating inflammatory responses. Furthermore, both strains regulated the expression of the CYP8B1, CYP7A1, SREBP-1, SCD1 and LDL-R gene to promote cholesterol metabolism and reduce TG accumulation. Interventions with both strains also altered the gut microbiota, and decreasing the abundance of Veillonellaceae, Erysipelotrichaceae and Prevotella. Furthermore, fecal acetic acid and propionic acid were increased by this intervention. Overall, the results suggested that E. faecium strain 132 and L. paracasei strain 201 can alleviate hypercholesterolemia in rats and might be applied as a new type of hypercholesterolemia agent in functional foods.</description><identifier>ISSN: 2072-6643</identifier><identifier>EISSN: 2072-6643</identifier><identifier>DOI: 10.3390/nu13061982</identifier><language>eng</language><publisher>MDPI AG</publisher><subject>Acetic acid ; Anticholesteremic agents ; Bile acids ; Cholesterol ; Hypercholesterolemia ; Inflammation ; Liver ; Low density lipoproteins ; Microbiota (Symbiotic organisms) ; Triglycerides</subject><ispartof>Nutrients, 2021-06, Vol.13 (6)</ispartof><rights>COPYRIGHT 2021 MDPI AG</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Yang, Lingshuang</creatorcontrib><creatorcontrib>Xie, Xinqiang</creatorcontrib><creatorcontrib>Li, Ying</creatorcontrib><creatorcontrib>Wu, Lei</creatorcontrib><creatorcontrib>Fan, Congcong</creatorcontrib><creatorcontrib>Liang, Tingting</creatorcontrib><creatorcontrib>Xi, Yu</creatorcontrib><creatorcontrib>Yang, Shuanghong</creatorcontrib><creatorcontrib>Li, Haixin</creatorcontrib><creatorcontrib>Zhang, Jumei</creatorcontrib><creatorcontrib>Ding, Yu</creatorcontrib><creatorcontrib>Xue, Liang</creatorcontrib><creatorcontrib>Chen, Moutong</creatorcontrib><creatorcontrib>Wang, Juan</creatorcontrib><creatorcontrib>Wu, Qingping</creatorcontrib><title>Evaluation of the Cholesterol-Lowering Mechanism of IEnterococcus faecium/I Strain 132 and ILactobacillus paracasei/I Strain 201 in Hypercholesterolemia Rats</title><title>Nutrients</title><description>Hypercholesterolemia can cause many diseases, but it can effectively regulated by Lactobacillus. This study aimed to evaluate the cholesterol-lowering mechanism of Enterococcus faecium strain 132 and Lactobacillusparacasei strain 201. These results showed that both the strains decreased serum total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), triglycerides (TG), liver TC and TG and increased fecal TC, TG and total bile acid (TBA) levels. Additionally, both strains also reduced glutamic-pyruvic transaminase (ALT), glutamic oxaloacetic transaminase (AST) and levels of tissue inflammation levels to improve the lipid profile, and they reduced fat accumulation partially by alleviating inflammatory responses. Furthermore, both strains regulated the expression of the CYP8B1, CYP7A1, SREBP-1, SCD1 and LDL-R gene to promote cholesterol metabolism and reduce TG accumulation. Interventions with both strains also altered the gut microbiota, and decreasing the abundance of Veillonellaceae, Erysipelotrichaceae and Prevotella. Furthermore, fecal acetic acid and propionic acid were increased by this intervention. Overall, the results suggested that E. faecium strain 132 and L. paracasei strain 201 can alleviate hypercholesterolemia in rats and might be applied as a new type of hypercholesterolemia agent in functional foods.</description><subject>Acetic acid</subject><subject>Anticholesteremic agents</subject><subject>Bile acids</subject><subject>Cholesterol</subject><subject>Hypercholesterolemia</subject><subject>Inflammation</subject><subject>Liver</subject><subject>Low density lipoproteins</subject><subject>Microbiota (Symbiotic organisms)</subject><subject>Triglycerides</subject><issn>2072-6643</issn><issn>2072-6643</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNptjlFLwzAQx4MoOOZe_AQBn7s1aZO0j2NMV6gIuveRXJIt0iajaRU_jN_VDoXtwbuH_3H3u7s_QvcknWdZmS78QLKUk7KgV2hCU0ETzvPs-qK-RbMY39NTiFTwbIK-1x-yGWTvgsfB4v5g8OoQGhN704UmqcOn6Zzf42cDB-ldbE9UtfanMQSAIWIrDbihXVT4re-k85hkFEuvcVVL6IOS4Jpm5I6ykyCjcWeSpgSPsvk6mg7Ob03rJH6VfbxDN1Y20cz-dIq2j-vtapPUL0_Valkney5IkukcbKG00JqBLkAbSSgrKRSKC8ZYmStRWio0ZWnOCsK4UKCIUoVh1oLOpujh9-xeNmbnvA2jPWhdhN1ScMbzPBdkpOb_UGPq0S8Eb6wb-xcLPwmAfAg</recordid><startdate>20210601</startdate><enddate>20210601</enddate><creator>Yang, Lingshuang</creator><creator>Xie, Xinqiang</creator><creator>Li, Ying</creator><creator>Wu, Lei</creator><creator>Fan, Congcong</creator><creator>Liang, Tingting</creator><creator>Xi, Yu</creator><creator>Yang, Shuanghong</creator><creator>Li, Haixin</creator><creator>Zhang, Jumei</creator><creator>Ding, Yu</creator><creator>Xue, Liang</creator><creator>Chen, Moutong</creator><creator>Wang, Juan</creator><creator>Wu, Qingping</creator><general>MDPI AG</general><scope/></search><sort><creationdate>20210601</creationdate><title>Evaluation of the Cholesterol-Lowering Mechanism of IEnterococcus faecium/I Strain 132 and ILactobacillus paracasei/I Strain 201 in Hypercholesterolemia Rats</title><author>Yang, Lingshuang ; Xie, Xinqiang ; Li, Ying ; Wu, Lei ; Fan, Congcong ; Liang, Tingting ; Xi, Yu ; Yang, Shuanghong ; Li, Haixin ; Zhang, Jumei ; Ding, Yu ; Xue, Liang ; Chen, Moutong ; Wang, Juan ; Wu, Qingping</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g671-3d4cf8bd7dd5cd8cdea12592c8b6755594b79f27d2504581567bcb1bb8e5ffcd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Acetic acid</topic><topic>Anticholesteremic agents</topic><topic>Bile acids</topic><topic>Cholesterol</topic><topic>Hypercholesterolemia</topic><topic>Inflammation</topic><topic>Liver</topic><topic>Low density lipoproteins</topic><topic>Microbiota (Symbiotic organisms)</topic><topic>Triglycerides</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yang, Lingshuang</creatorcontrib><creatorcontrib>Xie, Xinqiang</creatorcontrib><creatorcontrib>Li, Ying</creatorcontrib><creatorcontrib>Wu, Lei</creatorcontrib><creatorcontrib>Fan, Congcong</creatorcontrib><creatorcontrib>Liang, Tingting</creatorcontrib><creatorcontrib>Xi, Yu</creatorcontrib><creatorcontrib>Yang, Shuanghong</creatorcontrib><creatorcontrib>Li, Haixin</creatorcontrib><creatorcontrib>Zhang, Jumei</creatorcontrib><creatorcontrib>Ding, Yu</creatorcontrib><creatorcontrib>Xue, Liang</creatorcontrib><creatorcontrib>Chen, Moutong</creatorcontrib><creatorcontrib>Wang, Juan</creatorcontrib><creatorcontrib>Wu, Qingping</creatorcontrib><jtitle>Nutrients</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yang, Lingshuang</au><au>Xie, Xinqiang</au><au>Li, Ying</au><au>Wu, Lei</au><au>Fan, Congcong</au><au>Liang, Tingting</au><au>Xi, Yu</au><au>Yang, Shuanghong</au><au>Li, Haixin</au><au>Zhang, Jumei</au><au>Ding, Yu</au><au>Xue, Liang</au><au>Chen, Moutong</au><au>Wang, Juan</au><au>Wu, Qingping</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluation of the Cholesterol-Lowering Mechanism of IEnterococcus faecium/I Strain 132 and ILactobacillus paracasei/I Strain 201 in Hypercholesterolemia Rats</atitle><jtitle>Nutrients</jtitle><date>2021-06-01</date><risdate>2021</risdate><volume>13</volume><issue>6</issue><issn>2072-6643</issn><eissn>2072-6643</eissn><abstract>Hypercholesterolemia can cause many diseases, but it can effectively regulated by Lactobacillus. This study aimed to evaluate the cholesterol-lowering mechanism of Enterococcus faecium strain 132 and Lactobacillusparacasei strain 201. These results showed that both the strains decreased serum total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), triglycerides (TG), liver TC and TG and increased fecal TC, TG and total bile acid (TBA) levels. Additionally, both strains also reduced glutamic-pyruvic transaminase (ALT), glutamic oxaloacetic transaminase (AST) and levels of tissue inflammation levels to improve the lipid profile, and they reduced fat accumulation partially by alleviating inflammatory responses. Furthermore, both strains regulated the expression of the CYP8B1, CYP7A1, SREBP-1, SCD1 and LDL-R gene to promote cholesterol metabolism and reduce TG accumulation. Interventions with both strains also altered the gut microbiota, and decreasing the abundance of Veillonellaceae, Erysipelotrichaceae and Prevotella. Furthermore, fecal acetic acid and propionic acid were increased by this intervention. Overall, the results suggested that E. faecium strain 132 and L. paracasei strain 201 can alleviate hypercholesterolemia in rats and might be applied as a new type of hypercholesterolemia agent in functional foods.</abstract><pub>MDPI AG</pub><doi>10.3390/nu13061982</doi></addata></record>
fulltext fulltext
identifier ISSN: 2072-6643
ispartof Nutrients, 2021-06, Vol.13 (6)
issn 2072-6643
2072-6643
language eng
recordid cdi_gale_infotracmisc_A765644471
source Publicly Available Content Database; PubMed Central
subjects Acetic acid
Anticholesteremic agents
Bile acids
Cholesterol
Hypercholesterolemia
Inflammation
Liver
Low density lipoproteins
Microbiota (Symbiotic organisms)
Triglycerides
title Evaluation of the Cholesterol-Lowering Mechanism of IEnterococcus faecium/I Strain 132 and ILactobacillus paracasei/I Strain 201 in Hypercholesterolemia Rats
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T18%3A28%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluation%20of%20the%20Cholesterol-Lowering%20Mechanism%20of%20IEnterococcus%20faecium/I%20Strain%20132%20and%20ILactobacillus%20paracasei/I%20Strain%20201%20in%20Hypercholesterolemia%20Rats&rft.jtitle=Nutrients&rft.au=Yang,%20Lingshuang&rft.date=2021-06-01&rft.volume=13&rft.issue=6&rft.issn=2072-6643&rft.eissn=2072-6643&rft_id=info:doi/10.3390/nu13061982&rft_dat=%3Cgale%3EA765644471%3C/gale%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-g671-3d4cf8bd7dd5cd8cdea12592c8b6755594b79f27d2504581567bcb1bb8e5ffcd3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A765644471&rfr_iscdi=true